India's private hospital sector sees revenue surge as cancer caseloads overwhelm public system

Rising oncology demand is driving up to 25% of revenue for top private providers, highlighting a structural shift in healthcare spending as public facilities face capacity constraints.

By Handelsavisen Newsroom · Automated 2026-07-12 08:56 UTC · 1 min read

India's private healthcare sector is experiencing a significant revenue tailwind from oncology services, with cancer treatments now accounting for up to 25% of income for leading private hospital chains.

This surge is driven by a sharp increase in new cancer diagnoses, which the Indian Council of Medical Research (ICMR) estimates reached 15.7 lakh (1.57 million) cases in 2025.

This shift has intensified financial pressure on households, with out-of-pocket expenditure for timely cancer treatment frequently running into ₹20-30 lakh (approximately $24,000-$36,000) or more.

The growth in private sector revenue comes at a time when public hospitals are increasingly overstretched, forcing many patients to seek care in the private market.

This shift has intensified financial pressure on households, with out-of-pocket expenditure for timely cancer treatment frequently running into ₹20-30 lakh (approximately $24,000-$36,000) or more.

The high cost of care underscores the growing disparity between the rising demand for specialized medical services and the limited capacity of the public health infrastructure.

For investors, the data highlights the defensive nature of India's private healthcare providers, particularly those with strong oncology capabilities.